流量控制通气减轻猪急性呼吸窘迫综合征模型肺损伤:一项临床前随机对照研究
本研究为临床前随机对照动物实验,19头德国长白杂交猪经油酸诱导急性呼吸窘迫综合征后,分别接受流量控制通气(干预组)或容量控制通气(对照组),两组潮气量均为7 mL/kg、呼气末正压均为9 cm H2O。排除5头后每组7头。流量控制通气组动脉血氧分压更高(154 ± 21 托 vs 105 ± 9 托;20.5 ± 2.8 vs 14.0 ± 1.2 kPa;p = 0.035),动脉血二氧化碳分压相当(57 ± 3 vs 54 ± 1 托;7.6 ± 0.4 vs 7.1 ± 0.1 kPa;p = 0.37),分钟通气量更低(6.4 ± 0.5 vs 8.7 ± 0.4 L/min;p < 0.001)。流量控制通气还增加正常通气肺组织比例、减少依赖区无通气肺容积、减轻肺泡壁厚度与细胞浸润、提高支气管肺泡灌洗液中表面活性蛋白A浓度。作者认为控制呼气流速可能为肺保护性通气提供新选择。
要点
- 在油酸诱导的猪急性呼吸窘迫综合征模型中,流量控制通气较容量控制通气提高动脉血氧分压(154 ± 21 托 vs 105 ± 9 托;p = 0.035)。
- 流量控制通气在动脉血二氧化碳分压相当(57 ± 3 托 vs 54 ± 1 托;p = 0.37)的情况下,分钟通气量更低(6.4 ± 0.5 vs 8.7 ± 0.4 L/min;p < 0.001)。
- 流量控制通气增加依赖区正常通气肺组织比例(24% ± 4% vs 10% ± 2%;p = 0.004),减少依赖区无通气肺容积(23% ± 6% vs 38% ± 5%;p = 0.033)。
- 流量控制通气组肺泡壁更薄(5.5 ± 0.1 vs 7.8 ± 0.2 µm;p < 0.0001)、细胞浸润更少(20 ± 2 vs 32 ± 2 个/视野;p < 0.0001)、表面活性蛋白A浓度更高(1.1 ± 0.04 vs 1.0 ± 0.03;p = 0.039)。
- 两组吸气平台压相当(31 ± 2 vs 34 ± 2 cm H2O;p = 0.16),提示流量控制通气在相同潮气量和呼气末正压下即可实现上述效应。
适用人群与场景
- 19头德国长白杂交猪,经油酸诱导急性呼吸窘迫综合征后随机分组,5头被排除,最终每组7头。
- 动物实验场景,非急诊或ICU患者。
诊断标准与关键阈值
- 急性呼吸窘迫综合征由油酸诱导建立。
处置流程与药物剂量
- 干预组采用流量控制通气,对照组采用容量控制通气,两组潮气量均为7 mL/kg、呼气末正压均为9 cm H2O。
研究设计与关键结果
- 临床前随机对照动物研究,19头德国长白杂交猪,排除5头后每组7头;干预为流量控制通气,对照为容量控制通气,潮气量7 mL/kg、呼气末正压9 cm H2O。
- 主要气体交换结果:流量控制通气组动脉血氧分压154 ± 21 托(20.5 ± 2.8 kPa)vs 对照组105 ± 9 托(14.0 ± 1.2 kPa),p = 0.035;动脉血二氧化碳分压57 ± 3 托(7.6 ± 0.4 kPa)vs 54 ± 1 托(7.1 ± 0.1 kPa),p = 0.37;分钟通气量6.4 ± 0.5 vs 8.7 ± 0.4 L/min,p < 0.001;吸气平台压31 ± 2 vs 34 ± 2 cm H2O,p = 0.16。
- CT肺复张结果:流量控制通气组依赖区正常通气肺组织比例24% ± 4% vs 对照组10% ± 2%,p = 0.004;依赖区无通气肺容积23% ± 6% vs 38% ± 5%,p = 0.033。
- 肺损伤指标:流量控制通气组肺泡壁厚度5.5 ± 0.1 vs 7.8 ± 0.2 µm,p < 0.0001;细胞浸润20 ± 2 vs 32 ± 2 个/视野,p < 0.0001;支气管肺泡灌洗液归一化表面活性蛋白A浓度1.1 ± 0.04 vs 1.0 ± 0.03,p = 0.039。
证据类型、等级与局限
- 证据类型:临床前随机对照动物研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,控制呼气流速可能为肺保护性通气提供一种新选择。
- 本研究为动物实验,结果不能直接转化为急诊或ICU患者的临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Lung-protective ventilation for acute respiratory distress syndrome aims for providing sufficient oxygenation and carbon dioxide clearance, while limiting the harmful effects of mechanical ventilation. "Flow-controlled ventilation", providing a constant expiratory flow, has been suggested as a new lung-protective ventilation strategy. The aim of this study was to test whether flow-controlled ventilation attenuates lung injury in an animal model of acute respiratory distress syndrome.
DESIGN: Preclinical, randomized controlled animal study.
SETTING: Animal research facility.
SUBJECTS: Nineteen German landrace hybrid pigs.
INTERVENTION: Flow-controlled ventilation (intervention group) or volume-controlled ventilation (control group) with identical tidal volume (7 mL/kg) and positive end-expiratory pressure (9 cm H2O) after inducing acute respiratory distress syndrome with oleic acid.
MEASUREMENTS AND MAIN RESULTS: PaO2 and PaCO2, minute volume, tracheal pressure, lung aeration measured via CT, alveolar wall thickness, cell infiltration, and surfactant protein A concentration in bronchoalveolar lavage fluid. Five pigs were excluded leaving n equals to 7 for each group. Compared with control, flow-controlled ventilation elevated PaO2 (154 ± 21 vs 105 ± 9 torr; 20.5 ± 2.8 vs 14.0 ± 1.2 kPa; p = 0.035) and achieved comparable PaCO2 (57 ± 3 vs 54 ± 1 torr; 7.6 ± 0.4 vs 7.1 ± 0.1 kPa; p = 0.37) with a lower minute volume (6.4 ± 0.5 vs 8.7 ± 0.4 L/min; p < 0.001). Inspiratory plateau pressure was comparable in both groups (31 ± 2 vs 34 ± 2 cm H2O; p = 0.16). Flow-controlled ventilation increased normally aerated (24% ± 4% vs 10% ± 2%; p = 0.004) and decreased nonaerated lung volume (23% ± 6% vs 38% ± 5%; p = 0.033) in the dependent lung region. Alveolar walls were thinner (5.5 ± 0.1 vs 7.8 ± 0.2 µm; p < 0.0001), cell infiltration was lower (20 ± 2 vs 32 ± 2 n/field; p < 0.0001), and normalized surfactant protein A concentration was higher with flow-controlled ventilation (1.1 ± 0.04 vs 1.0 ± 0.03; p = 0.039).
CONCLUSIONS: Flow-controlled ventilation enhances lung aeration in the dependent lung region and consequently improves gas exchange and attenuates lung injury. Control of the expiratory flow may provide a novel option for lung-protective ventilation.
参考来源
- Schmidt J, Wenzel C, Spassov S, et al. Flow-Controlled Ventilation Attenuates Lung Injury in a Porcine Model of Acute Respiratory Distress Syndrome: A Preclinical Randomized Controlled Study. Crit Care Med. 2020. PMID: 31856000. doi:10.1097/CCM.0000000000004209
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。